A5039483609- Vaccine Coverage and Hesitancy
- Pneumonia and Respiratory Infections
- Bacterial Infections and Vaccines
- Cervical Cancer and HPV Research
- Hepatitis B Virus Studies
- Influenza Virus Research Studies
- Child and Adolescent Health
- Immune responses and vaccinations
- COVID-19 Impact on Reproduction
- Virology and Viral Diseases
- Reproductive System and Pregnancy
- Genital Health and Disease
- COVID-19 epidemiological studies
- Cystic Fibrosis Research Advances
- SARS-CoV-2 and COVID-19 Research
- Respiratory viral infections research
- Heparin-Induced Thrombocytopenia and Thrombosis
- COVID-19 Clinical Research Studies
- Immunodeficiency and Autoimmune Disorders
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Global Cancer Incidence and Screening
- IgG4-Related and Inflammatory Diseases
- Immunotherapy and Immune Responses
- Viral gastroenteritis research and epidemiology
- Antibiotic Use and Resistance
Norwegian Institute of Public Health
2015-2025
University of Oslo
2013
Norwegian Medicines Agency
2013
University of Bergen
2013
National Institute of Environmental Health Sciences
2013
London School of Hygiene & Tropical Medicine
2013
UiT The Arctic University of Norway
2013
Novartis (Italy)
2007
Novartis (Netherlands)
2007
During the 2009 influenza A (H1N1) pandemic, pregnant women were at risk for severe illness. This concern was complicated by questions about vaccine safety in that raised anecdotal reports of fetal deaths after vaccination.We explored vaccination linking Norwegian national registries and medical consultation data to determine diagnosis, status, birth outcomes, background information before, during, pandemic. We used Cox regression models estimate hazard ratios death, with gestational day as...
The Norwegian immunisation register, SYSVAK, is a national electronic register. It became nationwide in 1995. major aim was to register all vaccinations the Childhood Immunisation Programme ensure that children are offered adequate vaccination according schedule programme, and secure high coverage. Notification SYSVAK mandatory, based on personal identification numbers. This allows follow up of individual schedules linkage data other health registers for information outcome diagnoses, such...
Many signals of menstrual disturbances as possible side effects vaccination against COVID-19 have been reported. Our objective was to compare the risk before and after among women aged 18-30 years in Oslo, Norway. We used electronic questionnaires collect reports from 3972 years, participating population-based Norwegian Young Adult Cohort. examined occurrence (heavier bleeding than usual, prolonged bleeding, shorter interval between menstruations, longer spot bleedings, stronger pain during...
Objective Vaccine against human papillomavirus (HPV) has been offered free of charge to all 12-year-old girls in Norway since 2009. Nevertheless, the uptake HPV vaccine is lower than for other childhood vaccines. The aim this study was examine whether parental education and income are associated with initiation completion vaccination. Design Nationwide register-based study. Setting Publicly funded immunisation programme Norway. Participants 91 405 born between 1997 1999 registered Norwegian...
Vaccination has been suggested to be involved in the aetiology of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). HPV vaccine was introduced Norwegian Childhood Immunisation Programme and offered 12year old girls from 2009. We studied association between vaccination risk CFS/ME also assessed medical history relation both uptake.Individual data national registries, including Population Registry, Patient Registry were linked using unique personal identification number. Yearly...
BackgroundOlder age is associated with poorer outcomes to COVID-19 infection. The Norwegian Institute of Public Health established a longitudinal cohort adults aged 65–80 years study the effects pandemic. Here we describe characteristics in general, and specifically immune responses at baseline after primary booster vaccination subset blood samples, epidemiological factors affecting these responses.Methods4551 participants were recruited, humoral (n=299) cellular (n=90) measured before two...
In 2009, quadrivalent human papillomavirus (HPV) vaccine was introduced in a school-based single-cohort program targeting 12-year-old girls Norway. We estimated the impact of Norwegian HPV immunization program.Three birth cohorts 17-year-old girls, 2 nonvaccine-eligible (born 1994 or 1996) and 1 vaccine-eligible cohort 1997) were invited to deliver urine samples. The samples analyzed for 37 genotypes. prevalence compared between vaccinated unvaccinated within across after linkage...
Following the global call for action by World Health Organization to eliminate cervical cancer (CC), we evaluated how each CC policy decision in Norway influenced timing of elimination, and whether introducing nonavalent human papillomavirus (HPV) vaccine would accelerate elimination be cost-effective. We used a multi-modeling approach that captured HPV transmission carcinogenesis estimate incidence associated with six past future prevention decisions compared pre-vaccination scenario...
The association between coronavirus disease 2019 (COVID-19) vaccination and vaginal bleeding among nonmenstruating women is not well studied. Norwegian Institute of Public Health followed several cohorts throughout the pandemic early performed a systematic data collection self-reported unexpected in women. Among 7725 postmenopausal women, 7148 perimenopausal 7052 premenopausal 3.3, 14.1, 13.1% experienced during period 8 to 9 months, respectively. In risk (i.e., bleeding) 4 weeks after...
It has been suggested that non-live vaccines may increase susceptibility to non-targeted infections and such deleterious non-specific effects are more pronounced in girls. We investigated whether receipt of vaccine against human papillomavirus (HPV) was associated with increased risk infectious disease hospitalization. A nationwide cohort study based on detailed individual-level data from national registries performed Denmark, Finland, Norway, Sweden. The consisted girls aged 11-14 years...
Abstract Aim Estimate the incidence of asthma among children aged 0 to 15 years in Denmark, Finland, Norway and Sweden during 2000–2017. Methods Cases preschool (up 6 years) school‐age (from were identified through national registers using an algorithm including hospital diagnoses prescription medicines. The respective cumulative (CI) was estimated 1‐year age intervals for each country birth year. Results CI algorithm‐based peaked cohorts 2008 or 2009 at 14.8% 11.0% 15.1% 13.7% Sweden. For...
MenBvac and MeNZB are safe efficacious vaccines against serogroup B meningococcal disease. is prepared from a B:15:P1.7,16 strain (strain 44/76), B:4:P1.7-2,4 NZ98/254). At 6-week intervals, healthy adults received three doses of (25 microg), or the (doses 12.5 microg each vaccine) combined, followed by booster 1 year later. Two-thirds subjects who monovalent vaccine in primary schedule other as dose. The immune responses to combined were same magnitude homologous individual observed. 6...
To compare the use of antibiotics in children four Northern European countries.
ABSTRACT MenBvac is an outer membrane vesicle vaccine against systemic meningococcal disease caused by serogroup B Neisseria meningitidis . In this placebo-controlled double-blind study including 374 healthy adolescents, the safety and immunogenicity of a schedule three primary doses 6 weeks apart followed fourth dose year later were evaluated. Antibody responses to strain heterologous strains (non-vaccine-type strains) persistence these antibodies measured serum bactericidal assay (SBA)...
Understanding how booster vaccination can prevent moderate and severe illness without hospitalization is crucial to evaluate the full advantage of mRNA boosters.
During the 2009 influenza A (H1N1) pandemic, pregnant women were vulnerable to severe influenza, with increased risks of adverse fetal outcomes and maternal death. Pregnant advised be vaccinated in second or third trimester. After this national health data used assess effectiveness pandemic vaccine effect vaccination on survival. Information reproductive age Norway was linked registries. Of 1,153,738 females, aged 13 49 years, 117,026 gave birth 2010. The analyses included 113,331 women....
Abstract Background Since the human papillomavirus (HPV) vaccine was introduced in Norway 2009, uptake has increased. Whether this increase is similar regardless of girls’ country background unknown. We examined changes HPV from 2009 to 2014 and studied impact parental education income on according background. Methods Girls first six birth cohorts (1997–2002) eligible for vaccination were identified through National Registry. Information vaccination, socioeconomic factors extracted Norwegian...